Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Fraser

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Orphanet Journal of Rare Diseases|December 1, 2014
Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosisCedric Charrier, Catherine Rodger, Jennifer Robertson, et al.
Heart (British Cardiac Society)|June 21, 2011
GRACE risk recommendations in NICE CG94 are not appropriateElved Roberts, Mamas Mamas, Alice Wood, et al.
Biochemical and Biophysical Research Communications|August 19, 2023
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infectionDouglas Fraser-Pitt, Derry K Mercer, Marie-Louise Francis, et al.
European Heart Journal|June 20, 2008
Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routesTed S Lo, Azfar G Zaman, Rod Stables, et al.
Proteomics|January 27, 2011
Characterisation of proteins extracted from the surface of Salmonella Typhimurium grown under SPI-2-inducing conditions by LC-ESI/MS/MS sequencingAileen E Sherry, Neil F Inglis, Andy Stevenson, et al.
Clinical Drug Investigation|May 8, 2016
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic FibrosisGraham Devereux, Sandra Steele, Kairen Griffiths, et al.
Patient Education and Counseling|February 25, 2020
Improving remote lifestyle intervention studies in children: Participant and caregiver feedback of the smart heart studyMeghan Rombeek, Stefanie De Jesus, Harry Prapavessis, et al.
Injury Epidemiology|October 24, 2025
Safe system approach to preventing cyclist fatalities: safety by design for urban and rural environmentsTanya Charyk Stewart, Allison Pellar, Moheem Halari, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 2, 2020
Priority Outcomes in Critically Ill Children: A Patient and Parent PerspectiveNora Fayed, Saoirse Cameron, Douglas Fraser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSally A Frautschy, Kapil Manglani, Xiaohong Zuo, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Orphanet Journal of Rare Diseases|December 1, 2014
Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosisCedric Charrier, Catherine Rodger, Jennifer Robertson, et al.
Heart (British Cardiac Society)|June 21, 2011
GRACE risk recommendations in NICE CG94 are not appropriateElved Roberts, Mamas Mamas, Alice Wood, et al.
Biochemical and Biophysical Research Communications|August 19, 2023
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infectionDouglas Fraser-Pitt, Derry K Mercer, Marie-Louise Francis, et al.
European Heart Journal|June 20, 2008
Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routesTed S Lo, Azfar G Zaman, Rod Stables, et al.
Proteomics|January 27, 2011
Characterisation of proteins extracted from the surface of Salmonella Typhimurium grown under SPI-2-inducing conditions by LC-ESI/MS/MS sequencingAileen E Sherry, Neil F Inglis, Andy Stevenson, et al.
Clinical Drug Investigation|May 8, 2016
An Open-Label Investigation of the Pharmacokinetics and Tolerability of Oral Cysteamine in Adults with Cystic FibrosisGraham Devereux, Sandra Steele, Kairen Griffiths, et al.
Patient Education and Counseling|February 25, 2020
Improving remote lifestyle intervention studies in children: Participant and caregiver feedback of the smart heart studyMeghan Rombeek, Stefanie De Jesus, Harry Prapavessis, et al.
Injury Epidemiology|October 24, 2025
Safe system approach to preventing cyclist fatalities: safety by design for urban and rural environmentsTanya Charyk Stewart, Allison Pellar, Moheem Halari, et al.
American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|September 2, 2020
Priority Outcomes in Critically Ill Children: A Patient and Parent PerspectiveNora Fayed, Saoirse Cameron, Douglas Fraser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisSally A Frautschy, Kapil Manglani, Xiaohong Zuo, et al.
Pageof 7